Marishka DeToy is an associate in the firm’s Business Law Department and a member of its Life Sciences group.

Ms. DeToy has a broad capital markets practice representing issuers and underwriters in a range of transactions, including initial public offerings, follow-on public offerings, high-yield and investment-grade bond offerings, ATMs, PIPEs and tender offers. She also represents public and private companies in their ongoing corporate matters, including SEC compliance and corporate governance.

Areas of Practice
业务范围
Domaines D’Expertise
TÄTIGKEITSFELDER

Experience

工作经历

EXPÉRIENCE

ERFAHRUNG

Ms. DeToy’s experience includes, among others, representation of:

  • BioDelivery Sciences International in its definitive acquisition by Collegium Pharmaceutical for $604 million
  • BeiGene in its $3.5 billion initial public offering on STAR Market of the Shanghai Stock Exchange in China
  • Vaccitech plc in its $40 million acquisition of Avidea Technologies
  • The underwriters in Alphatec’s $316.2 million convertible note offering
  • The underwriters in Omega Therapeutics’ $125.8 million initial public offering 
  • Monte Rosa Therapeutics in its $222.3 million initial public offering
  • Vaccitech plc in its $110 million initial public offering
  • Vaccitech plc in its $168 million Series B financing
  • argenx NV in its $557 million and $1.15 billion follow-on offerings
  • Goldman Sachs as lead underwriter in Taysha Gene Therapies, Inc.’s $181 million initial public offering
  • BeiGene in its $2.08 billion registered direct offering and $340 million follow-on offering
  • The underwriters in Evelo Biosciences’ $72.6 million follow-on offering
  • Fusion Pharmaceuticals Inc. in its $212.5 million initial public offering
  • The underwriters in SQZ Biotechnologies Company’s $70 million initial public offering and $60 million follow-on offering
  • scPharmaceuticals in its $50 million follow-on offering
  • Avadel Pharmaceuticals in its $65 million financing transaction and $125 million follow-on offering
  • Black Diamond Therapeutics in its $231.3 million initial public offering
  • Black Diamond Therapeutics in its $85 million Series C financing
  • BeiGene in its $2.7 billion global strategic collaboration with Amgen
  • Celyad SA in its $20 million follow-on offering and $32.5 million private placement
  • Bicycle Therapeutics in its $60 million initial public offering
  • BioDelivery Sciences International in its $60 million follow-on offering
  • Kaleido Biosciences in its $75 million initial public offering
  • Aerpio Pharmaceuticals in its $45 million follow-on offering

Recognition

Ms. DeToy has been recognized as a “Rising Star” in The Legal 500 2022 in the Healthcare: Life Sciences category.

In The News

相关新闻

ACTUALITÉS

MELDUNGEN

Credentials

专业资格

RÉFÉRENCES

WERDEGANG

Education

J.D., 2015
Georgetown University Law Center
A.B., 2009
Georgetown University

Admissions

Bar

New York
Massachusetts
Profile Image
Get In Touch
联系我们
NOUS CONTACTER
Kontakt
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
搜寻其他律师
Recherche par Pratique
ANWALTSSUCHE